A Prospective Study of Inflammatory Markers and Risk of Endometriosis
article
OA: bronze
CC0
⤵ 60 in-corpus citations
AI-generated summary
This prospective study found that elevated plasma interleukin-1 beta and soluble tumor necrosis factor α receptor 2 levels were associated with a higher risk of endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Much evidence suggests a role for inflammation in the pathogenesis of endometriosis. Although investigators in numerous case-control studies have found elevation of inflammatory markers in patients with endometriosis, results were not consistent, and no prior prospective study is known to exist. We conducted a case-control study nested within the Nurses' Health Study II in which we examined associations between levels of plasma inflammatory markers (interleukin-1 beta, interleukin-6, soluble tumor necrosis factor α receptors 1 and 2, and high-sensitivity C-reactive protein) and the risk of laparoscopically confirmed endometriosis. From blood collections in 1996-1999 and 2007, we ascertained 350 cases patients with incident endometriosis and 694 matched controls. Women with interleukin-1 beta levels in quintiles 2-4 had a higher risk of endometriosis (for the second quintile, relative risk (RR) = 3.30, 95% confidence interval (CI): 1.06, 10.3; for the third quintile, RR = 3.36, 95% CI: 1.09, 10.4; and for the fourth quintile, RR = 4.64, 95% CI: 1.58, 13.6; P for trend = 0.62), which suggested an association beginning at 0.47 pg/mL or greater. A significant nonlinear association with levels of soluble tumor necrosis factor α receptor 2 was observed, with elevated risk of endometriosis at concentrations greater than 3,400 pg/mL. Plasma interleukin-6, soluble tumor necrosis factor α receptor 1, and high-sensitivity C-reactive protein levels were not associated with endometriosis risk. Further research in larger studies with younger age at blood collection and longer time from blood to surgical diagnosis are required to confirm these associations.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (36)
- Adhesion of endometrial cells labeled with 111Indium-tropolonate to peritoneum: a novel in vitro model to study endometriosis via openalex
- Angiogenic Factors in Endometriosis via openalex
- Behaviour of Cytokine Levels in Serum and Peritoneal Fluid of Women with Endometriosis via openalex
- Correlation between endometriosis and pelvic pain via openalex
- Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro via openalex
- Effect of tumor necrosis factor-α on adhesion of human endometrial stromal cells to peritoneal mesothelial cells: an in vitro system via openalex
- Endometriosis via openalex
- Endometriosis and Risk of Coronary Heart Disease via openalex
- Endometriosis: Interaction of Immune and Endocrine Systems via openalex
- Immunobiology of endometriosis via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Peritoneal Cellular Immunity and Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal Fluid lnterleukin‐1β and Tumor Necrosis Factor in Patients With Benign Gynecologic Disease via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- Role of cytokines in endometriosis via openalex
- Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis via openalex
- The use of biochemical markers in the diagnosis of pelvic endometriosis via openalex
- What makes a good case–control study? via openalex
- W2109820701 via openalex
- W2125921569 via openalex
- W2135721067 via openalex
- W2049037562 via openalex
- W2042642675 via openalex
- W2028712686 via openalex
- W2171863626 via openalex
- W2015220984 via openalex
- W2001244638 via openalex
- W1977671182 via openalex
- W4211081176 via openalex
- W1964920982 via openalex
- W2098787760 via openalex
- W6628680024 via openalex
Cited by (50)
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- The association between shorter disease course and sarcopenia in women with endometriosis: a retrospective analysis of NHANES 1999–2006 2025
- Aspirin does not modify cardiovascular event risk in endometriosis in the California Teachers Study 2025
- The interplay between migraine, endometriosis and polycystic ovarian syndrome: A systematic review 2025
- Associations between biological aging and the risk of endometriosis: Evidence from a large population-based prospective cohort study 2025
- Association of Systemic Inflammatory Markers With Endometrioma Diagnosis and Douglas Involvement: A Retrospective Analysis 2025
- Prospective evaluation of plasma proteins in relation to surgical endometriosis diagnosis in the Nurses’ Health Study II 2025
- Enhanced analysis of endometriosis patients’ plasma using #Enzian annotation highlights potential biomarkers for early-stages of disease 2025
- Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies 2025
- Association between vitamin D and endometriosis among American women: National Health and Nutrition Examination Survey 2024
- Genetic evidence for causal effects of immune cell traits on risk for endometriosis: a bidirectional two-sample Mendelian Randomization Study 2024
- Research Progress on the Pathogenesis of Endometriosis 2024
- Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives 2024
- Determination of cytokines for assessment of inflammatory status at genital endometriosis 2024
- The association between shorter disease course and sarcopenia in women with endometriosis: A retrospective analysis of NHANES 1999-2006 2024
- Identification of Key miRNAs in Endometriosis 2024
- Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy 2023
- Sphingosine 1‐phosphate elicits a ROS‐mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 2023
- Expression Profiles of Genes Related to Development and Progression of Endometriosis and Their Association with Paraben and Benzophenone Exposure 2023
- Neurotrophins and Their Receptors, Novel Therapeutic Targets for Pelvic Pain in Endometriosis, Are Coordinately Regulated by IL-1β via the JNK Signaling Pathway 2023
- Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders 2023
- Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma 2023
- Association between endometriosis and risk of type 2 diabetes: Results from the prospective E3N cohort 2023
- Pregnancy outcomes among women with endometriosis and fibroids: registry linkage study in Massachusetts 2022
- Circulating proteomic profiles associated with endometriosis in adolescents and young adults 2022
- Colocalization of senescent biomarkers in deep, superficial, and ovarian endometriotic lesions: a pilot study 2022
- The gut microbiota and endometriosis: From pathogenesis to diagnosis and treatment 2022
- Laparoscopically Confirmed Endometriosis and Risk of Incident Stroke: A Prospective Cohort Study 2022
- The gut microbiota: a double-edged sword in endometriosis 2022
- Impact of curcumin, quercetin, or resveratrol on the pathophysiology of endometriosis: A systematic review 2022
- Glycemic Index, Glycemic Load, Fiber, and Gluten Intake and Risk of Laparoscopically Confirmed Endometriosis in Premenopausal Women 2022
- Could endometriosis increase the severity of COVID-19 infection symptoms? 2022
- Endometriosis, Psoriasis, and Psoriatic Arthritis: A Prospective Cohort Study 2022
- Morphological and molecular features of recurrent endometrioid ovarian cysts 2022
- Effect of early inflammatory reaction on ovarian reserve after laparoscopic cystectomy for ovarian endometriomas 2022
- Localização de células senescentes nas lesões de pacientes com endometriose profunda 2022
- Potential link between the nerve injury-induced protein (Ninjurin) and the pathogenesis of endometriosis 2022
- Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate 2021
- The role of the immune response in the etiopathogenesis of endometriosis 2021
- The role of gut and genital microbiota and the estrobolome in endometriosis, infertility and chronic pelvic pain 2021
- Intricate Connections between the Microbiota and Endometriosis 2021
- Inflammatory Mediators and Pain in Endometriosis: A Systematic Review 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Endometriosis and adverse pregnancy outcome 2021
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Target identification and drug discovery by data-driven hypothesis and experimental validation in ovarian endometriosis 2021
- The study of endometriosis and adenomyosis related microbiota in female lower genital tract in Northern Chinese population 2021
- Peripheral Blood Leukocyte Telomere Length and Endometriosis 2020
- Adverse Pregnancy Outcomes in Endometriosis – Myths and Realities 2020
- Recreational and residential sun exposure and risk of endometriosis: a prospective cohort study 2020
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:13.663096+00:00
License: CC0
· commercial use OK